Financials data is unavailable for this security.
View more
Year on year China Traditional Chinese Medicine Holdings Co Ltd grew revenues 26.69% from 14.30bn to 18.12bn while net income improved 68.11% from 764.49m to 1.29bn.
Gross margin | 49.86% |
---|---|
Net profit margin | 5.77% |
Operating margin | 5.80% |
Return on assets | 2.62% |
---|---|
Return on equity | 4.38% |
Return on investment | 4.01% |
More ▼
Cash flow in CNYView more
In 2023, China Traditional Chinese Medicine Holdings Co Ltd did not generate a significant amount of cash. However, the company earned 1.17bn from its operations for a Cash Flow Margin of 6.45%. In addition the company used 477.62m on investing activities and also paid 584.31m in financing cash flows.
Cash flow per share | 0.4463 |
---|---|
Price/Cash flow per share | 5.06 |
Book value per share | 4.56 |
---|---|
Tangible book value per share | 2.69 |
More ▼
Balance sheet in CNYView more
Current ratio | 2.08 |
---|---|
Quick ratio | 1.51 |
Total debt/total equity | 0.2494 |
---|---|
Total debt/total capital | 0.1808 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share fell -100.00% while earnings per share excluding extraordinary items rose 68.11%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg) | 1.45% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 0.00% |
EPS growth(5 years) | -3.08 |
---|---|
EPS (TTM) vs TTM 1 year ago | -1.31 |
More ▼